Table 3.
Clinical outcomes
| Group-1 | Group-2 | p | |
|---|---|---|---|
|
|
|||
| n=104 | n=36 | ||
| In-hospital | |||
| TLR | 8 (7.7) | 0 (0.0) | 0.1 |
| Death | 5 (4.8) | 1 (2.8) | 0.96 |
| MACE | 13 (12.5) | 1 (2.8) | 0.1 |
| 6-month | |||
| Non-Q-MI | 2 (1.9) | 0 (0.0) | 0.98 |
| Q-MI | 0 (0.0) | 0 (0.0) | - |
| TLR | 19 (18.3) | 1 (2.8) | 0.044 |
| TVR | 19 (18.3) | 1 (2.8) | 0.044 |
| Death | 5 (4.8) | 1 (2.8) | 1.0 |
| MACE | 24 (23.1) | 2 (5.6) | 0.037 |
MI: Myocardial infarction; TLR: Target Lesion Revascularization; TVR: Target Vessel Revascularization; MACE: Major Adverse Cardiac Event.